FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061977 [Registered on: 29/01/2024] Trial Registered Prospectively
Last Modified On: 02/09/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Prospective Observational 
Study Design  Other 
Public Title of Study   International and observational study to understand the medical procedures performed to prevent and relieve airway obstruction during surgery 
Scientific Title of Study   International obServational sTudy on AiRway manaGement in operAting room and non-operaTing room anaEsthesia (STARGATE) 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
4284_Version 1.3 dated July 2023  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai


MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sheila Nainan Myatra 
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Department of Anesthesia Critical care and Pain Tata Memorial Centre Dr E Borges Road Parel Mumbai


MAHARASHTRA
400012
India 
Phone  9820156070  
Fax    
Email  sheila150@hotmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesia, Critical Care and Pain, Tata Memorial Hospital, Mumbai 400012 
 
Primary Sponsor  
Name  Università degli Studi di Torino 
Address  Università degli Studi di Torino Via Verdi, 8 - 10124 Torino 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     Australia
Croatia
France
India
Ireland
Italy
Turkey
United Kingdom
United States of America  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sheila Nainan Myatra  Tata Memorial Hospital  Department of Anesthesia Critical care and Pain, Second floor, Major OT complex, Main Building, Tata Memorial Centre Dr E Borges Road Parel Mumbai
Mumbai
MAHARASHTRA 
9820156070

sheila150@hotmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethics Committee ll, Tata Memorial Hospital  Approved 
Institutional Ethics Committee,Sir H.N. Reliance Foundation Hospital and Research Centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NA 
Comparator Agent  NIL  NA 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  All adult patients undergoing advanced airway management (either tracheal intubation or supraglottic airway device, SGA placement) for general anaesthesia in the operating room (OR) or non-operating room (NORA) locations 
 
ExclusionCriteria 
Details  1. Airway management during cardiopulmonary resuscitation.
2. Critically ill patients undergoing advanced airway management due to their
underlying clinical condition. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
At least one of the following major adverse events during airway management occurring within 30 minutes from induction or up to surgical incision
1. Severe hypoxia (SpO2 less than 80 percentage)
2. Cardiovascular collapse (at least one of the following)
a. Systolic arterial pressure less than 65 mmHg
b. Systolic arterial pressure less than 90 mmHg for more than 15 minutes
c. Unplanned need of vasopressors or fluid load more than 15 ml per kg to
maintain the target blood pressure 
within 30 minutes from induction or up to surgical incision 
 
Secondary Outcome  
Outcome  TimePoints 
1. Minor adverse events during airway management
o Moderate hypoxia (SpO2 less than 93percent)
o Airway injury
o Clinically relevant bleeding
o Oral aspiration of gastric contents
o Dental injury
2. Difficult facemask ventilation
3. First pass success rate
 
within 30 minutes from induction or up to surgical incision 
 
Target Sample Size   Total Sample Size="10500"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  01/02/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Rationale
According to WHO, more than 230 million major surgical procedures are carried out under general anaesthesia each year worldwide. Despite important technological advances, airway management remains a major challenge in anaesthesiology. Data from large prospective studies on current incidence of major peri-intubation adverse events are lacking in the anaesthesia setting, especially on outcomes such as periintubation cardiovascular collapse, severe hypoxemia, and cardiac arrest. These events are more common in case of difficulties with airway management so that first pass intubation failure significantly increases the risks. Moreover, it has been documented that even transient hypotension during general anaesthesia, may have long-term consequences and may be associated with a worse outcome in patients undergoing non-cardiac surgery. The primary aim of the study is to assess the current incidence of major adverse events during advanced airway management in anaesthesia in patients undergoing elective or emergency surgery performed in the operating room (OR) and in the setting of nonoperating room anaesthesia (NORA). The secondary aim is to assess the current practice of airway management during anaesthesia worldwide.

Study design
International, multicentre, prospective cohort study

Data collection
We will collect the following information: 
1. Informed consent and admission data 
2. Demographic and clinical characteristics 
3. Type of procedure (time, setting, type of surgery, elective or emergency 
4.  Airway evaluation (anticipated difficult airway management) 
5. Monitoring applied during the procedure 
6. Patient’s parameters 
7. Preoxygenation method and use of apnoeic oxygenation (position during preoxygenation, rapid sequence induction applied) 
8. Drugs used for induction (specific drug and doses) 
9. Elective method of airway management 
10. Operator’s characteristics 
11. Method used for the second (and following) attempts 
12. Method used for adequate tube placement confirmation 
13. Duration of the procedure 
14. Outcome of endotracheal intubation (total number of attempts, laryngoscopy view, minimum SpO2 during laryngoscopy, need for SGA) 
15. Advanced airway management-related complications (severe cardiovascular collapse, severe and mild hypoxemia, cardiac arrest, airway injury or any bleeding, aspiration of gastric contents, dental injury, emergency front of neck airway (eFONA), cannot intubate cannot oxygenate scenario (CICO), unplanned need for ICU secondary to airway management complications) 
16. Extubation procedure. 
17. In-hospital mortality.

Statistical analysis 
We will report mean and standard deviation of normally distributed variables and we will compare them using the student T-test. We will report non-normally distributed variables as median and interquartile range, comparing them using the Mann-Whitney U test. Categorical variables will be expressed as proportion and compared using the Chi-square or Fisher exact test as appropriate. We will perform a bivariate analysis to identify variables associated with the composite outcome of major peri-intubation adverse events and significant variables will be then used to construct a multivariate logistic model in order to identify independent variables. The following planned secondary analyses will be performed: 
 1. Place of advanced airway management: OR vs NORA 
 2. Type of surgery: cardiac vs non-cardiac surgery 
 3. Urgency of the procedure: planned advanced airway management vs unplanned advanced airway management 
 4. Type of hypnotic drug used: propofol vs different drug 
 5. Airway management procedure: difficult airway management vs not difficult 
 6. Patient’s condition: a. ASA 1-2 vs ASA 3-4; b. BMI<30 vs BMI>30; 
 A two-sided p-value < 0.05 will be considered statistically significant. Statistical analysis will be performed by IBM SPSS Statistics for Macintosh, Version 28.0. Armonk, NY: IBM Corp.

PUBLICATION AND AUTHORSHIP POLICY 
The main results of STARGATE study will be published in a peer–reviewed international medical journal. Authorship policy will follow the International Committee of Medical Journal Editors (ICMJE) recommendations. Authorship will be considered based on contributions to recruitment of patients, data acquisition and cleaning, analysis and interpretation of the data, manuscript writing, submission of national/local grants AND final approval of the version to be published AND agreement to be accountable for all aspects of the work, in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. 
Members of the Steering Committee will be part of the Writing Committee and listed as Authors. National Coordinators and particularly committed investigators fulfilling the previously exposed criteria will be part of the Writing Committee. Each centre will designate local coordinators who will provide scientific and structural leadership in their centres. They will ensure that all local necessary ethical and regulatory approvals are obtained before the start of patient inclusion. Local coordinators will guarantee the integrity of data collection and ensure timely completion of CRFs. Local coordinators will be listed as study collaborators in proportion to the number of recruited patients in each center.
 
Close